The Effect of Exercise Rehabilitation based on Different Exercise Prescriptions on the Lp-PLA2, BPV and HRV of the CHD patients after percutaneous coronary intervention

The effect of exercise rehabilitation on lipoprotein phosphorus esterase A2 based on 6-minute walk test in coronary heart disease patients after percutaneous coronary intervention

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048124

Enrollment

Unknown

Registered

2021-07-03

Start date

2019-01-01

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Group A:standardized medication, including antiplatelet, beta blockers, angiotensin II receptor blockers, statins, and so on

Group B:exercise rehabilitation based on 6-MWT

Group C:exercise rehabilitation based on exercise treadmill test

Group D:exercise rehabilitation based on CPX

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the CHD patients accomplished PCI

Exclusion criteria

Exclusion criteria: respiratory system diseases such as chronic obstructive pulmonary disease, obvious abnormal liver and kidney function,New York heart function class III - IV, uncontrolled hypertension or type 2 diabetes or arrhythmia, unable to cooperate with movement, intolerance for aerobic exercise training etc.

Design outcomes

Primary

Measure	Time frame
lipoprotein phosphorus esterase A2(Lp-PLA2);Heart Rate Variability;Blood Pressure Variability;	—

Secondary

Measure	Time frame
blood lipid;homocysteine;	—

Countries

China

Contacts

Public ContactXiangyang Liu

Yuebei People's Hospital

longliu0714@sina.com+86 13553640790

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026